To the best of our knowledge, the current study involves the largest number of cases of any clinical study date, regarding the analysis of the prognostic significance of metabolic and volumetric parameters derived from 18F-FDG PET/CT in advanced lung adenocarcinoma patients with the EGFR mutation. The gene discussed is EGFR; the disease is lung adenocarcinoma.